Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03946618 · ClinicalTrials.gov registry record · NA

Neurophysiologically Based Brain State Tracking and Modulation in Focal Epilepsy

A NA study of Epilepsy, sponsored by Mayo Clinic.

Active
Registry status
NA
Development phase
5
Enrollment target
1
Study location

NCT03946618: Active NA study of Epilepsy, sponsored by Mayo Clinic.

NCT03946618 is a NA study of Epilepsy that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 5 participants, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03946618, a NA study of Epilepsy, is active but no longer recruiting, sponsored by Mayo Clinic.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
5 participants
Enrollment target
1
Study location

Study Summary

Researchers are trying to determine if tracking seizure occurrence, seizure probability, behavioral state, cognition, and mood can be achieved using an implantable brain sensing and stimulation device (Medtronic RC+S Summit) coupled to an external, handheld, patient assistant device (PAD) with capability for patient interaction (patient data input). The system (RC+S \& PAD) provides intracranial EEG (iEEG) sensing, electrical brain stimulation, and machine learning algorithms running on the RC+S and PAD that will be coupled with electrical brain stimulation (EBS) to prevent seizures and improve quality of life in patients with epilepsy.

Conditions Studied

Epilepsy

Interventions

  • DEVICE Medtronic Summit System, Olympus

Study Locations (1)

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2019-01-18
Est. Completion 2027-02
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03946618

The ClinicalTrials.gov registry entry for NCT03946618 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (99% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Epilepsy appearing as the primary indexed condition, and to 1 intervention - of which Medtronic Summit System, Olympus is the first listed.

NCT03946618 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT03946618 about?

NCT03946618 is a clinical study titled "Neurophysiologically Based Brain State Tracking and Modulation in Focal Epilepsy". Researchers are trying to determine if tracking seizure occurrence, seizure probability, behavioral state, cognition, and mood can be achieved using an implantable brain sensing and stimulation device (Medtronic RC+S Summit) coupled to an external, handheld, patient assistant device (PAD) with capab...

What is the current status of trial NCT03946618?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 5 participants. The study started on 2019-01-18. Estimated completion is 2027-02.

What conditions does trial NCT03946618 study?

This clinical trial studies the following conditions: Epilepsy.

What interventions are being tested in trial NCT03946618?

The interventions under investigation include: Medtronic Summit System, Olympus (DEVICE).

Who is sponsoring clinical trial NCT03946618?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03946618 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Epilepsy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Epilepsy

All registered trials for this condition

Minnesota

All trials with a study site in Minnesota

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.